| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |